Real-time imaging with the sonographic contrast agent SonoVue:differentcation of benign and malignaut hypoechoic focal lesions in fatty liver
Weijun Huang
Abstract
Weijun Huang
Abstract
Objective:We use real-time contrast-enhanced ultrasound(CEUS)technique with the sonographic contrast agent SonoVue to diagnosis between benign and malignant hypoechoic focal lesions in fatty liver.Methods:We studied 41 hypoechoic liver lesions(in 33 patients) found on conventional grayscale sonography with contrat-enhanced ultrasonography.Final diagnosis was made using contrast enhanced helical CT,contrast enhanced MR,and histopathic confirmation or clinical imaging follow-up.Results:There were 7 malignant lesions demonstrated:2 hepatocellular carcinomas,3 metastatic carcinomas,1 cholangiocellular carcinomas and 1 non-hodgkin′s 1ymphoma.34 benign lesions demonstrated:11 hemangiomas,5 focal nodular hyperplasias(FNH),18 focal areas of sparing in hepatic steatosis.CEUS characterized 33/34 benign lesions and 7/7 malignant lesions.Conclusion:CEUS with SonoVue contrast agent can distinguish malignant from benign hypoechoic lesions in fatty liver.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:We use real-time contrast-enhanced ultrasound(CEUS)technique with the sonographic contrast agent SonoVue to diagnosis between benign and malignant hypoechoic focal lesions in fatty liver.Methods:We studied 41 hypoechoic liver lesions(in 33 patients) found on conventional grayscale sonography with contrat-enhanced ultrasonography.Final diagnosis was made using contrast enhanced helical CT,contrast enhanced MR,and histopathic confirmation or clinical imaging follow-up.Results:There were 7 malignant lesions demonstrated:2 hepatocellular carcinomas,3 metastatic carcinomas,1 cholangiocellular carcinomas and 1 non-hodgkin′s 1ymphoma.34 benign lesions demonstrated:11 hemangiomas,5 focal nodular hyperplasias(FNH),18 focal areas of sparing in hepatic steatosis.CEUS characterized 33/34 benign lesions and 7/7 malignant lesions.Conclusion:CEUS with SonoVue contrast agent can distinguish malignant from benign hypoechoic lesions in fatty liver.
Key concepts: Medicine, Ultrasonography, Radiology, Focal nodular hyperplasia, Ultrasound, Contrast-enhanced ultrasound, Hepatocellular carcinoma, Contrast enhancement